ICM
ANIK icon

Invenomic Capital Management’s Anika Therapeutics ANIK Stock Holding History

Invenomic Capital Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-210,332
Closed -$4.77M – 148
2023
Q4 		$4.77M Buy
210,332
+116,679
+125% +$2.41M 0.25% 112
2023
Q3 		$1.74M Buy
+93,653
New +$1.94M 0.07% 132
2022
Q4 		– Sell
-140,312
Closed -$3.34M – 142
2022
Q3 		$3.34M Sell
140,312
-3,975
-3% -$91.5K 0.29% 98
2022
Q2 		$3.22M Buy
+144,287
New +$3.22M 0.28% 102

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return